Back to Search
Start Over
Immunologic resilience and COVID-19 survival advantage.
- Source :
-
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2021 Nov; Vol. 148 (5), pp. 1176-1191. Date of Electronic Publication: 2021 Sep 08. - Publication Year :
- 2021
-
Abstract
- Background: The risk of severe coronavirus disease 2019 (COVID-19) varies significantly among persons of similar age and is higher in males. Age-independent, sex-biased differences in susceptibility to severe COVID-19 may be ascribable to deficits in a sexually dimorphic protective attribute that we termed immunologic resilience (IR).<br />Objective: We sought to examine whether deficits in IR that antedate or are induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection independently predict COVID-19 mortality.<br />Methods: IR levels were quantified with 2 novel metrics: immune health grades (IHG-I [best] to IHG-IV) to gauge CD8 <superscript>+</superscript> and CD4 <superscript>+</superscript> T-cell count equilibrium, and blood gene expression signatures. IR metrics were examined in a prospective COVID-19 cohort (n = 522); primary outcome was 30-day mortality. Associations of IR metrics with outcomes in non-COVID-19 cohorts (n = 13,461) provided the framework for linking pre-COVID-19 IR status to IR during COVID-19, as well as to COVID-19 outcomes.<br />Results: IHG-I, tracking high-grade equilibrium between CD8 <superscript>+</superscript> and CD4 <superscript>+</superscript> T-cell counts, was the most common grade (73%) among healthy adults, particularly in females. SARS-CoV-2 infection was associated with underrepresentation of IHG-I (21%) versus overrepresentation (77%) of IHG-II or IHG-IV, especially in males versus females (P < .01). Presentation with IHG-I was associated with 88% lower mortality, after controlling for age and sex; reduced risk of hospitalization and respiratory failure; lower plasma IL-6 levels; rapid clearance of nasopharyngeal SARS-CoV-2 burden; and gene expression signatures correlating with survival that signify immunocompetence and controlled inflammation. In non-COVID-19 cohorts, IR-preserving metrics were associated with resistance to progressive influenza or HIV infection, as well as lower 9-year mortality in the Framingham Heart Study, especially in females.<br />Conclusions: Preservation of immunocompetence with controlled inflammation during antigenic challenges is a hallmark of IR and associates with longevity and AIDS resistance. Independent of age, a male-biased proclivity to degrade IR before and/or during SARS-CoV-2 infection predisposes to severe COVID-19.<br /> (Published by Elsevier Inc.)
- Subjects :
- Adult
Aged
COVID-19 epidemiology
COVID-19 mortality
Cohort Studies
Disease Resistance
Female
Humans
Immunocompetence
Interleukin-6 blood
Longitudinal Studies
Male
Middle Aged
Prospective Studies
Severity of Illness Index
Survival Analysis
Transcriptome immunology
United States epidemiology
Viral Load
COVID-19 immunology
HIV Infections epidemiology
HIV-1 physiology
Respiratory Insufficiency epidemiology
SARS-CoV-2 physiology
Sex Factors
T-Lymphocytes immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1097-6825
- Volume :
- 148
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- The Journal of allergy and clinical immunology
- Publication Type :
- Academic Journal
- Accession number :
- 34508765
- Full Text :
- https://doi.org/10.1016/j.jaci.2021.08.021